Doubling times and CT screen-detected lung cancers in the Pittsburgh lung screening study

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 1, 2012, Pages 85-89

  Wilson, David O ^a   Ryan, Adam ^a   Fuhrman, Carl ^a   Schuchert, Matthew ^b   Shapiro, Steven ^a   Siegfried, Jill M ^a   Weissfeld, Joel ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Doubling times; Lung cancer; Lung cancer screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SCREENING; CELL DIFFERENTIATION; CELL TYPE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; FEMALE; FISHER EXACT TEST; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG NODULE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VOLUMETRY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CONE-BEAM COMPUTED TOMOGRAPHY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; OBSERVER VARIATION; PENNSYLVANIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, SPIRAL COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855295455     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201107-1223OC     Document Type: Article

References (16)

1. The National Lung Screening Trial Research Team. Reduced lungcancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Wilson D, Weissfeld J, Fuhrman C, Fisher S, Balogh P, Landreneau R, Luketich J, Siegfried J. The Pittsburgh Lung Cancer Screening Study (PluSS): outcomes within 3 years of prevalence CT scan. Am J Respir Crit Care Med 2008;178:956-961.
3. Revel MP, Merlin A, Peyrard S, Triki R, Couchon S, Chatellier S, Frija G. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. Am J Roentgenol 2006;187: 135-142. (Pubitemid 46100159)
4. Petrou M, Quint L, Nan B, Baker L. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology. Am J Roentgenol 2007;188:306-312. (Pubitemid 46167729)
5. Quint L, Cheng J, Schipper M, Chang A, Kalemkerian G. Lung lesion doubling times: values and variability based on method of volume determination. Clin Radiol 2008;63:41-48. (Pubitemid 350212860)
6. Hasegawa M, Sone S, Takashimi S, Yang ZG, Maruyama Y, Watanabe T. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-1259. (Pubitemid 32123826)
7. Lindell R, Hartman T, Swensen S, Jett JR, Midthun DE, Tazelaar HD, Madrekar JN. Five year lung cancer screening experience: CT appearance, growth rate, location and histologic features of 61 lung cancers. Radiology 2007;242:555-562. (Pubitemid 46146208)
8. Winer-Muram H, Jennings S, Tarver R, Aisen AM, Tann M, Conces DJ, Meyer CA. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 2002;223:798-805. (Pubitemid 34547600)
9. Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H, Yasumoto K, Kido M. Evolution of peripheral lung adenocarcinomas; CT findings correlated with histology and tumor doubling time. Am J Roentgenol 2000;174:763-768. (Pubitemid 30126259)
10. Jennings S, Winer-Muram H, Tann M, Ying J, Dowdeswell I. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology 2006;241:554-563. (Pubitemid 44632903)
11. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178:738-744.
12. Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst 2006;98:637-640. (Pubitemid 43904847)
13. Spitz MR, Hong WK, Amos CI, Wu X, Shabath MB, Dong Q, Shete S, Etzel CJ. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-726. (Pubitemid 47073532)
14. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, van Iersel CA, van den Bergh KA, van't Westeinde S, nan der Aalst C, et al. Management of lung nodules detected by volume CT scanning. N Engl JMed 2009;361:2221-2229.
15. Yankelevitz DF, Henschke CI. Does 2 year stability imply that pulmonary nodules are benign? Am J Roentgenol 1997;168:325.
16. Petro M, Quint LE, Nan B, Baker LH. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology. Am J Roentgenol 2007;188:306-312. (Pubitemid 46167729)